Molecular Docking Human Plasma Kallikrein to Prevent Acute Respiratory Distress Syndrome(ARDS) in COVID-19 Patient

Keyphrases

• Molecular Docking 100%
• α-mangostin 100%
• Human Plasma 100%
• Autodock 4.2 100%
• Acute Respiratory Distress Syndrome 100%
• COVID-19 Patients 100%
• Plasma Kallikrein 100%
• Binding Energy 50%
• Active Compounds 50%
• Medicinal Plants 50%
• Medical Treatment 50%
• Clinical Manifestations 50%
• Severe Complications 50%
• Silico 50%
• Inflammatory Mediators 50%
• Medicinal Plant Compounds 50%
• SARS-CoV-2 Infection 50%
• Bisdemethoxycurcumin 50%
• COVID-19 Complications 50%
• Nafamostat 50%
• Bradykinin 50%
• Xanthohumol 50%
• Kinins 50%
• Kallikrein Inhibitor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Adult Respiratory Distress Syndrome 100%
• Plasma Kallikrein 100%
• Medicinal Plant 66%
• Infection 33%
• Combination Therapy 33%
• SARS Coronavirus 33%
• Demethoxycurcumin 33%
• Nafamstat 33%
• Bradykinin 33%
• Xanthohumol 33%
• Kinin 33%
• Kallikrein Inhibitor 33%

INIS

• kinins 33%